A detailed history of Fairmount Funds Management LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Fairmount Funds Management LLC holds 2,360,077 shares of AXSM stock, worth $205 Million. This represents 34.46% of its overall portfolio holdings.

Number of Shares
2,360,077
Previous 2,360,077 -0.0%
Holding current value
$205 Million
Previous $190 Million 11.61%
% of portfolio
34.46%
Previous 37.71%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$57.42 - $83.61 $1.08 Million - $1.58 Million
18,839 Added 0.8%
2,360,077 $188 Million
Q3 2023

Nov 14, 2023

SELL
$69.25 - $82.21 $259,133 - $307,629
-3,742 Reduced 0.16%
2,341,238 $164 Million
Q2 2023

Aug 14, 2023

BUY
$58.41 - $90.35 $19.5 Million - $30.1 Million
333,333 Added 16.57%
2,344,980 $169 Million
Q4 2022

Feb 14, 2023

BUY
$39.94 - $79.72 $4.59 Million - $9.17 Million
115,000 Added 6.06%
2,011,647 $155 Million
Q3 2022

Nov 09, 2022

BUY
$36.06 - $69.85 $34.4 Million - $66.6 Million
954,076 Added 101.22%
1,896,647 $84.6 Million
Q1 2022

May 16, 2022

BUY
$23.7 - $41.39 $17.9 Million - $31.2 Million
754,973 Added 402.44%
942,571 $39 Million
Q3 2021

Nov 15, 2021

SELL
$19.91 - $68.26 $2.49 Million - $8.53 Million
-125,000 Reduced 39.99%
187,598 $6.18 Million
Q2 2021

Aug 13, 2021

BUY
$50.63 - $73.5 $3.09 Million - $4.48 Million
61,000 Added 24.25%
312,598 $21.1 Million
Q1 2021

May 14, 2021

BUY
$55.91 - $81.44 $1.76 Million - $2.57 Million
31,500 Added 14.31%
251,598 $14.2 Million
Q3 2020

Nov 12, 2020

BUY
$68.34 - $85.84 $273,360 - $343,360
4,000 Added 1.85%
220,098 $15.7 Million
Q2 2020

Aug 04, 2020

BUY
$49.87 - $98.69 $1.32 Million - $2.62 Million
26,500 Added 13.98%
216,098 $17.8 Million
Q1 2020

May 08, 2020

BUY
$41.2 - $101.31 $7.81 Million - $19.2 Million
189,598 New
189,598 $11.2 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.73B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Fairmount Funds Management LLC Portfolio

Follow Fairmount Funds Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairmount Funds Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairmount Funds Management LLC with notifications on news.